Subscribe
to get our
LATEST NEWS
Related Posts
Read More Articles
Medicinal Chemistry & Pharmacology
April 14, 2026
Igor Nasonkin and Phythera Therapeutics: Moving Oncology Beyond Single Targets into Engineered Polypharmacologic Systems
Igor Nasonkin’s systems-driven approach at Phythera Therapeutics reframes oncology drug development from single-target inhibition to AI-enabled polypharmacologic network modulation using nature-derived molecular architectures.
Artificial Intelligence and Data Analytics
April 10, 2026
Inside Johnson & Johnson’s External Innovation Engine: Devin Swanson on Translating Integrated Discovery into Strategic Value
Devin Swanson’s leadership at Johnson & Johnson Innovative Medicines redefines external innovation as a tightly governed, AI-enabled translational system integrating multi-modal drug discovery, biomarker strategy, and capital-efficient execution.
Immunology & Oncology
April 9, 2026
From DMPK to Distributed Execution: Mehran F. Moghaddam’s Systems Strategy at OROX BioSciences, Inc.
A systems-level examination of how Mehran F. Moghaddam operationalizes DMPK, externalized R&D, and lipid-mediated therapeutics into a predictive, high-velocity biotech development architecture.
Artificial Intelligence and Data Analytics
March 31, 2026
From Data to Decision: Shicheng Guo’s Systems Approach to AI-Enabled Drug Development
A systems-level analysis of how Shicheng Guo is architecting AI-driven, human data–centric drug development at Arrowhead Pharmaceuticals.